Tuesday, January 20, 2009 11:14:11 AM
Let's see. The company is reducing the AS almost 10 fold and is getting geared up for mass production and distribution in March and April fo this year. What's not to like here?
Recent RAPH News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/06/2026 10:22:31 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 08:01:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 08:01:19 PM
- Raphael Pharmaceutical Announces Filing of Provisional Patent Application for the Treatment of Neutrophil-Dominant Autoimmune Diseases, Including Rheumatoid Arthritis (RA) • GlobeNewswire Inc. • 11/17/2025 05:03:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 09:02:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 08:06:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2025 08:05:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2025 11:00:57 AM

